Focus on recent approaches for the development of new NO-donors

Mini-Reviews in Medicinal Chemistry

Volumn 5, Issue 2, 2005, Pages 217-229

  Gasco, Alberto ^a   Fruttero, R ^a   Rolando, B ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Drug NO donor hybrids; Nitric oxide; NO delivery systems; NO donor antioxidants; NO donor targeting; NO donors

Indexed keywords

1,4 DIHYDROPYRIDINE DERIVATIVE; 4,5 DIAMINOFLUORESCEIN DIACETATE; ACETYLSALICYLIC ACID DERIVATIVE; AMYL NITRITE; CALCIUM CHANNEL BLOCKING AGENT; DICLOFENAC DERIVATIVE; FRUCTOSE 1 N ACETYL S NITROSOPENICILLAMINE; FRUCTOSE 2 N ACETYL S NITROSOPENICILLAMINE; FURAZAN DERIVATIVE; GLUCOSE 2 N ACETYL S NITROSOPENICILLAMINE; GLYCERYL TRINITRATE; HYDROCORTISONE DERIVATIVE; IBUPROFEN DERIVATIVE; MOLSIDOMINE; N ACETYL S NITROSOPENICILLAMINE; NCX 1004; NCX 1015; NITRIC ACID DERIVATIVE; NITRIC OXIDE DONOR; NITRITE; NITROPRUSSIDE SODIUM; NITROSO DERIVATIVE; NITROXIDE DERIVATIVE; OXIME DERIVATIVE; PREDNISOLONE DERIVATIVE; RABEPRAZOLE; S NITROSOCYSTEINE; S NITROSOTHIOL; UNCLASSIFIED DRUG; UNINDEXED DRUG; URSODEOXYCHOLIC ACID DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; HUMAN; NONHUMAN; REVIEW; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; SYSTEMATIC REVIEW;

EID: 14544304642     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389557053402684     Document Type: Review

References (101)

1. Kerwin, J.F. Jr.; Heller, M. Med. Res. Rev., 1994 14, 23.
2. Kerwin, J.F. Jr.; Lancaster, J.R. Jr.; Feldman, P.L. J. Med. Chem., 1995, 38, 4343.
3. Lipton, S.A.; Stamler, J.S.; Singel, D.J. Nature, 1994, 28, 367.
4. Stamler, J.S.; Singel, D.J.; Loscalzo, J. Science, 1992, 258, 1898.
5. Horowitz, J.D. In Nitric Oxide and the Cardiovascular System; Loscalzo, J.; Vita J.A.; Eds.; Humana Press: Totowa, New Jersey, 2000; pp. 383-409.
6. Tatcher, G.R.; Weldon, H. Chem. Soc. Rev., 1998, 27, 331.
7. Schröder, H. Adv. Drug. Res., 1996, 28, 253.
8. Chen, Z.; Zhang, J.; Stamler, J.S. Proc. Natl. Acad. Sci. U. S. A., 2002, 99, 8306.
9. Abrams, J.; Elkayam, U.; Thadani, U.; Fung, H.-L. Am. J. Cardiol., 1998, 81 (1A) 3A-14A.
10. Wang, K.; Zhang, W.; Xian, M.; Hou, Y.-C.; Chen, X.-C.; Cheng, J.-P.; Wang, P.G. Curr. Med. Chem., 2000, 7, 821.
11. Richardson, G.; Benjamin, N. Clin. Sci., 2002, 102, 99.
12. Megson, I.L.; Morton, S.; Greig, I.R.; Mazzei, F.A.; Field, R.A.; Butler, A.R.; Caron, G.; Gasco, A.; Fruttero, R.; Webb, D.J. Br. J. Pharmacol., 1999, 126, 639.
13. Askew, S.C.; Barnett, D.J.; McAninly, J.; Williams, D.L.H. J. Chem. Soc. Perkin Trans. 2, 1995, 741.
14. Dicks, A.P.; Swift, H.R.; Williams, D.L.H.; Butler, A.R.; Al-Sa'doni, H.H.; Cox, B.G. J. Chem. Soc. Perkin Trans. 2, 1996 481.
15. Megson, I.L.; Greig, I.R.; Gray, G.A.; Webb, D.J.; Butler, A.R. Br. J. Pharmacol., 1997, 122, 1617.
16. Butler, A.R.; Al-Sa'doni, H.H.; Megson, I.L.; Flitney, F.W. Nitric Oxide, 1998, 2, 193.
17. Al-Sa'doni, H.H.; Khan, I.Y.; Poston, L.; Fisher, I.; Ferro, A. Nitric Oxide, 2000, 4, 550
18. Hrabie, J.A.; Keefer, L.K. Chem. Rev., 2002, 102, 1135.
19. Keefer, L.K. CHEMTECH., 1998, 28, 30.
20. Wang, P.G.; Xian, M.; Tang, X.; Wu, X.; Wen, Z.; Cai, T.; Janczuk. A.J. Chem. Rev., 2002, 102, 1091.
21. Feelisch, M.; Stamler, J.S. In Methods in Nitric Oxide Research; Feelisch, M. and Stamler, J.S. Eds.; John Wiley & Sons: New York, 1996; pp. 71-115.
22. (a) Granik, V.G.; Ryabova, S.Y.; Grigoriev, N.B. Russ. Chem. Rev., 1997, 66, 717.
23. (b) Granik, V.G.; Grigoriev, N.B. Russ. Chem. Bull. Int. Ed., 2002, 51, 1375.
24. Berliner, J.A.; Navab, M.; Fogelman, A.M.; Frank, J.S.; Demer, L.L.; Edwards, P.A.; Watson, A.D.; Lusis, A.J. Circulation, 1995, 91, 2488.
25. Keaney, J.F. Jr.; Vita, J.A. Prog. Cardiovasc. Dis., 1995, 38, 129.
26. Rekka, E.A.; Chrysselis, M.C. Mini Rev. Med. Chem., 2002, 2, 585.
27. Chrysselis, M.C.; Rekka, E.A.; Siskou, I.C.; Kourounakis, P.N. J. Med. Chem., 2002, 45, 5406.
28. Chrysssselis, M.C.; Rekka, E.A.; Kourounakis, P.N. J. Med. Chem., 2000, 43, 609.
29. Kurowska, E.M.; Carroll, K.K. Biochim. Biophys. Acta, 1998, 1392, 41.
30. Samuni, A.M.; Barenholz, Y. Free Radical Biol. Med., 2003, 34, 177.
31. Offer, T.; Samuni, A. Free Radical Biol. Med., 2002 32, 872.
32. Fedeli, D.; Damiani, E.; Greci, L.; Littaru, G.P.; Falcioni, G. Mutat. Res-Gen. Tox. En., 2003, 535 (2), 117.
33. Änggård, E.E.; Haj-Yehia, A.I. U.S. Patent 6,455,542. B1, 2002.
34. Haj- Yehia, A.; Nassar, T.; Lotan, T.; Münzel, Benet, L.; Änggård; E.E. Drug. Develop. Res., 2000, 50, 528.
35. Zhang, Z.; Naughton, D.P.; Sumi, Y.; Imaizumi, A. U.S. Patent 6,346,634, 2002.
36. Petit, C.; Bernardes-Genisson, V.; Hoffmann, P.; Souchard, J.P.; Labidalle, S. Braz. J. Med. Biol. Res., 1999, 32, 1407.
37. Kelm, M. Biochim. Biophys. Acta, 1999, 1411, 273.
38. Andreassi, M.G.; Picano, E.; DelRy, S.; Botto, N.; Colombo, M.G.; Giannessi, D.; Lubrano, V.; Vassalle, C.; Bigini, A. Mutagenesis 2001, 16, 517.
39. Saavedra, J.E.; Dunams, T.M.; Filippen-Anderson, J.L.; Kefeer; L.K. J. Org. Chem., 1992, 58, 1472.
40. Saavedra, J.E.; Billiar, T,R.; Williams, D.L.; Kim, Y.-M.; Watkins, S.C.; Keefer, L.K. J. Med. Chem., 1997, 40, 1947.
41. Tang, X.; Xian, M.; Trikha, M.; Honn, K.V.; Wang, P.G. Tetrahedron Lett., 2001, 42, 2625.
42. Wu, X.; Tang, X.; Xian, M.; Wang; P.G. Tetrahedron Lett. 2001, 42, 3779.
43. Shami, P.J.; Saavedra, J.E.; Wang, L.Y.; Bonifant, C.L.; Diwan, B.A.; Singh, S.V.; Gu, Y.; Fox, S.D.; Buzard, G.S.; Citro, M.L.; Waterhouse, D.J.; Davies K.M.; Ji, X.; Keefer, L.K. Mol. Cancer, Ther. 2003, 2, 409.
44. Ramirez, J.; Yu, L.; Li, J.; Braunschweiger, P.G.; Wang, P.G. Bioorg. Med. Chem. Lett., 1996, 6, 2575.
45. Hou, Y.C.; Wang, J.-Q.; Ramirez, J.; Wang. P.G.; Method. Enzymol., 1999, 301, 242.
46. Wu, X; Tang, X.; Xian, M.; Brauschweiger, P.G.; Wang; P.G. Bioorg. Med. Chem., 2002, 10, 2303.
47. Hou, Y.C.; Wang, J.; Andreana, P.R.; Cantauria, G.; Tarasia, S.; Sharp, L.; Braunschweiger, P.G.; Wang; P.G. Bioorg. Med. Chem. Lett., 1999, 9, 2255.
48. Hou, Y.; Wu, X.; Xie, W.; Braunschweiger, P.G.; Wang, P.G. Tetrahedron Lett., 2001, 42, 825.
49. Fleisch, H. Bisphosphonates in Bone Disease, The Parthenon Publishing Group: New York, London, 1997.
50. Fiorucci, S.; Mencarelli, A.; Palazzetti, B.; Del Soldato, P.; Morelli, A.; Ignarro, L.J. Proc. Natl. Acad Sci. U. S. A., 2001, 98, 2652.
51. Fiorucci, S.; Antonelli, E.; Morelli, O.; Mencarelli, A.; Casini, A.; Mello, T.; Palazzotti, B.; Tallet, D.; Del Soldato, P.; Morelli, A. Proc. Natl. Acad. Sci. U. S. A., 2001, 98, 8897.
52. Royer, R. In Actualités de Chimie. Thérapeutiques 4éme série, société de chimie thérapeutique (sct), 1976 37.
53. Nicolaus, B.J.R. In Decision Making in Drug Research; F. Gross, Ed.; Raven Press: New York, 1983; pp. 173-186.
54. Baldwin, J.J. In Drug Discovery Development; M. Williams, J.B. Malick, Eds.; Humana Press: Clifton, New Jersey, 1987 pp. 33-71.
55. Christiaans, J.A.M.; Timmerman, H. Eur. J. Pharm. Sci., 1996, 4, 1.
56. Gasco, A.; Fruttero, R.; Sorba, G. Farmaco, 1996, 51, 617.
57. Wallace, J.L.; Del Soldato, P.; Cirino, G.; Muscarà, M.N. Drugs, 1999, 2, 321.
58. Bandarage, U.K.; Janero, D.R. Mini Rev. Med. Chem. 2001, 1, 57.
59. Keeble, J.E.; Moore, P.K. Br. J. Pharmacol., 2002 137, 295.
60. Napoli, C.; Ignarro, L.J. Annu. Rev. Pharmacol. Toxicol. 2003, 43, 97.
61. Wallace, J.; Granger, D.N. FASEB J., 1996, 10 731.
62. Whitehouse, M.W.; Rainsford, K.D.J. Pharm. Pharmacol., 1980, 32, 795.
63. Nielsen, N.M.; Bundgaard, H. J. Med. Chem. 1989, 32, 727.
64. Burgaud, J.L.; Riffaud, J.P.; Del Soldato, P. Curr. Pharm. Design, 2002, 8, 201.
65. Tallet, D.; Del Soldato, P.; Oudart, N.; Burgaud, J.L. Biochem. Biophys. Res. Commun., 2002, 290 (1), 125.
66. Turesin, F.; Del Soldato, P.; Wallace, J.L. Br. J. Pharmacol., 2003, 139, 966.
67. Baraldi, P.G.; Romagnoli, R.; Nuñez, M.; Perretti, M.; Paul-Clark, M.J.; Ferrario, M.; Govoni, M.; Benedini, F.; Ongini, E. J. Med. Chem., 2004, 47, 711.
68. Lehmann, J.; Kahlich, R.; Meyer zum Gottesberge, C.; Fricke, U. Arch. Pharm. Pharm. Med. Chem. (Weinheim, Ger.), 1997, 330, 247.
69. Nguyen, J.-T., McEwen, C.-A.; Knaus, E. Drug Der. Res., 2000, 51, 233.
70. Wessler, C.; Diewald, D.; Lehmann, J. Eur. J. Pharm. Sci. 1998, 6 (suppl. 1), S37.
71. Shan, R.; Howlett, S.E.; Knaus, E.E. J. Med. Chem., 2002, 45, 955.
72. Rojstaczer, N.; Triggle, D.J. Biochem. Pharmacol., 1996, 51, 141.
73. Sobal, G.; Menzel, E.J.; Sinzinger, H. Biochem. Pharmacol. 2001, 61, 373.
74. Saavedra, J.E.; Booth, M.N.; Harabie, J.A.; Davies, K.M.; Keefer, L.K. J. Org. Chem., 1999, 64, 5124.
75. Gasco, A.; Boulton, A.J. Adv, Heterocycl. Chem., 1981, 29, 251.
76. Khmel'nitskii, L.I.; Novikov, S.S.; Godovikova, T.I. Chemistry of Furoxans: Structure and synthesis.
77. Khmel'nitskii, L.I.; Novikov, S.S.; Godovikova, T.I. Chemistry of Furoxans: Reaction and use. 2nd ed; M. Nauka, 1996 (in Russian).
78. Ghigo, R.; Heller, P.; Calvino, R.; Alessio, R.; Fruttero, R.; Gasco, A.; Bosia, A.; Pescarmona, G.P. Biochem. Pharmacol., 1992, 43, 1281.
79. Feelisch, M.; Shönafinger, K.; Noack, E. Biochem. Pharmacol., 1992, 44, 1149.
80. Hecker, M.; Vorhoff, W.; Bara, A.T.; Mordvintcev, P.I.; Busse, R. Naunyn Schmiedeberg's Arch. Pharmacol., 1995, 351, 426.
81. Cerecetto, H.; Porcal, W. Mini Rev. Med. Chem. in press.
82. Vo, D.; Nguyen, J.-T.; Mc.Ewen, C.-A.; Shan, R.; Knaus, E.E. Drug Dev. Res., 2002, 56, 1.
83. Boschi, D.; Tron, G.C.; Di Stilo, A.; Fruttero, R.; Gasco, A.; Poggesi, E.; Motta, G.; Leonardi, A. J. Med. Chem., 2003, 46, 3762.
84. Sorba, G.; Galli, U.; Cena, C.; Fruttero, R.; Gasco, A.; Morini, G.; Adami, M.; Coruzzi, G.; Brenciaglia, M.I.; Dubini, F. ChemBioChem., 2003, 4, 899.
85. Cena, C.; Lolli, M.L.; Lazzarato, L.; Guaita, E.; Morini, G.; Coruzzi, G.; McElroy, S.P.; Megson, I.L.; Fruttero, R.; Gasco, A. J. Med. Chem., 2003, 46, 747.
86. Di Stilo, A.; Visentin, S.; Cena, C.; Gasco, A.M.; Ermondi, G; Gasco, A. J. Med. Chem., 1998, 41, 5393.
87. Mannick, J.B. Res. Immunol., 1995, 146, 693.
88. Marcinkiewicz, J. Immunopharmacology, 1997, 37 35.
89. Bertinaria, M.; Galli, U.; Sorba, G.; Fruttero, R.; Gasco, A.; Brenciaglia, M.I.; Scaltrito, M.M.; Dubini, F. Drug. Dev. Res., 2003, 60, 225.
90. Sannella, A.; Gradoni, L.; Persichini, T.; Ongini, E.; Venturini, G.; Colasanti, M. Antimicrob. Agents Chemother., 2003 47, 2303.
91. Smith, D.J.; Chakravarthy, D.; Keefer, L.K.; U.S. Patent 5,691,423, 1997.
92. Parzuchowski, P.G.; Frost, M.C.; Meyerhoff, M. J. Am. Chem. Soc., 2002, 124, 12181.
93. Smith, D.J.; Chakravarthy, D.; Pulfer, S.; Simmons, M.L.; Hrabie, J.A.; Citro, M.L. J. Med. Chem., 1996, 39, 1148.
94. Saavedra, J.; Keefer, L. Chem. Brit., 2000, 36 30.
95. Nablo, B.J.; Chen, T.-Y.; Schoenfisch, M.H. J. Am. Chem. Soc., 2001, 123, 9712.
96. Oh, B.K.; Meyerhoff, M.E. J. Am. Chem. Soc., 2003 125, 9552.
97. Bohl, K.S.; West, J.L. Biomaterials, 2000, 21 2273.
98. Stamler, J.S.; Simon, D.I.; Osborne, J.A.; Mullins, M.E.; Jaraki, O.; Singel, D.J.; Loscalzo, J. Proc. Natl. Acad. Sci. U. S. A. 1992, 89, 444.
99. Keaney, J.F.; Simon, D.I.; Stamler, J.S.; Jaraki, O.; Scharfstein, J.; Vita, J.A.; Loscalzo, J. J. Clin. Invest., 1993 91, 1582.
100. Maalej, N.; Albrecht, R.; Loscalzo, J.; Folts, J.D. J. Am. Coll. Cardiol., 1999, 33, 1408.
101. Davidson, R.N.; Yardley, V.; Croft, S.L.; Konecny, P.; Benjamin, N. Trans R. Soc. Trop. Med. Hyg., 2000, 94, 319.